Markets.com Logo

TYRA

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    10.2259$
  • Previous Close
    11.6905$
  • 52 Week Change
    23.18$
  • Day Range
    -1.46$
  • 52 Week High/Low
    6.42$ - 29.6$
  • Dividend Per Share
    --
  • Market cap
    546 M$
  • EPS
    -0.47
  • Beta
    1.084
  • Volume
    --

About

TYRA.US refers to shares of Tyra Biosciences, Inc. trading on the Nasdaq Stock Market. Tyra Biosciences is a precision oncology company focused on developing therapies to overcome tumor resistance and improve outcomes for patients with cancer. The company uses its SnapDragon platform to rapidly design and discover purpose-built therapies that address specific oncogenic drivers. Tyra Biosciences is headquartered in Carlsbad, California.

Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence

Noah Lee|--

Global Markets Show Resilience Amidst Iran Conflict, But Underlying Risks Persist

Emma Rose|--

Iran War Threatens US Labor Market's 'Wonderful Balance': A Deep Dive

Emma Rose|--

Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment

Sophia Claire|--

US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks

Sophia Claire|--

Global Debt Crisis Deepens Amidst Iran Conflict and Fiscal Fragility

Ava Grace|--

Apple's Strategic Pivot: MacBook Neo, Supply Chain Tactics, and Foldable Phone Hurdles

Emma Rose|--

Factors

Company Performance: Strong earnings, revenue growth, and positive profit margins typically drive the stock price up. Conversely, poor financial performance can lead to a decline.

Industry Trends: The overall health and growth prospects of the fashion industry significantly influence Tyra Biosciences' stock. Positive industry trends generally support higher stock valuations.

Market Sentiment: General investor confidence and risk appetite play a role. Bullish market conditions tend to lift most stocks, while bearish conditions can depress prices, even for fundamentally sound companies.

Drug Pipeline Progress: Progress or setbacks in the development and approval of Tyra Biosciences' drug candidates are major catalysts for price fluctuations. Positive trial results boost investor confidence, while regulatory hurdles can negatively impact the stock.

Competition: The competitive landscape within the pharmaceutical industry influences Tyra Biosciences' market share and potential revenue. The emergence of new competing therapies can create downward pressure.

Economic Factors: Macroeconomic conditions such as interest rates, inflation, and economic growth can affect investor sentiment and overall market valuations, impacting the price of TYRA.US.

Regulatory Environment: Changes in regulations governing the pharmaceutical industry, including drug approvals and pricing, can have a material impact on Tyra Biosciences' future prospects and stock price.

People Also Watch

Latest news

Close Coordination Between Israel and US on Iran Nuclear Talks Highlighted

Noah Lee|--

US-Iran Talks Show Progress Towards Ceasefire Framework Agreement

Liam James|--

Federal Reserve Independence Under Historic Test: Navigating Democratic Legitimacy and Political Pressure

Liam James|--

Latest Education Articles

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Julian Parker|--
Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Julian Parker|--
Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Frances Wang|--
Recommended Topics